Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.
about
The potential applications of Apolipoprotein E in personalized medicineThe Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathwayTotal apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.Cerebral microbleeds in early Alzheimer's disease.
P2860
Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cerebrospinal fluid apolipopro ...... diagnosed Alzheimer's disease.
@en
Cerebrospinal fluid apolipopro ...... diagnosed Alzheimer's disease.
@nl
type
label
Cerebrospinal fluid apolipopro ...... diagnosed Alzheimer's disease.
@en
Cerebrospinal fluid apolipopro ...... diagnosed Alzheimer's disease.
@nl
prefLabel
Cerebrospinal fluid apolipopro ...... diagnosed Alzheimer's disease.
@en
Cerebrospinal fluid apolipopro ...... diagnosed Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Cerebrospinal fluid apolipopro ...... diagnosed Alzheimer's disease.
@en
P2093
Christian Schmidt
Harry Becker
P2860
P356
10.1177/1533317513505133
P407
P577
2013-11-24T00:00:00Z